Growth Metrics

Veracyte (VCYT) Other Non Operating Income: 2012-2025

Historic Other Non Operating Income for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to -$4.1 million.

  • Veracyte's Other Non Operating Income fell 183.98% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 59.31%. This contributed to the annual value of $9.6 million for FY2024, which is 4.56% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Other Non Operating Income is -$4.1 million, which was down 162.24% from $6.5 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Other Non Operating Income registered a high of $6.5 million during Q2 2025, and its lowest value of -$4.1 million during Q3 2025.
  • Moreover, its 3-year median value for Other Non Operating Income was $2.7 million (2024), whereas its average is $2.3 million.
  • Over the last 5 years, Veracyte's Other Non Operating Income had its largest YoY gain of 3,528.57% in 2021, and its largest YoY loss of 1,985.71% in 2021.
  • Quarterly analysis of 5 years shows Veracyte's Other Non Operating Income stood at $1.0 million in 2021, then soared by 94.78% to $2.0 million in 2022, then skyrocketed by 154.42% to $5.0 million in 2023, then slumped by 114.54% to -$732,000 in 2024, then plummeted by 183.98% to -$4.1 million in 2025.
  • Its Other Non Operating Income stands at -$4.1 million for Q3 2025, versus $6.5 million for Q2 2025 and $4.5 million for Q1 2025.